We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.64%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$34.8B
AUM Growth
+$3.48B
Cap. Flow
+$9.84B
Cap. Flow %
28.29%
Top 10 Hldgs %
40.9%
Holding
1,487
New
119
Increased
700
Reduced
287
Closed
311

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.2B
2
NVDA icon
NVIDIA
NVDA
+$662M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$581M
4
MU icon
Micron Technology
MU
+$479M
5
AVGO icon
Broadcom
AVGO
+$470M

Sector Composition

Rank Sector Weight
1 Technology 34.26%
2 Real Estate 23.49%
3 Communication Services 13.02%
4 Consumer Discretionary 6.46%
5 Financials 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVRA icon
1401
Savara
SVRA
$1.13B
-553
Closed -$3K
SYRE icon
1402
Spyre Therapeutics
SYRE
$8.87B
-258
Closed -$8K
TARS icon
1403
Tarsus Pharmaceuticals
TARS
$2.56B
-137
Closed -$11K
TBPH icon
1404
Theravance Biopharma
TBPH
$874M
-115
Closed -$2K
TERN
1405
DELISTED
Terns Pharmaceuticals
TERN
-260
Closed -$11K
TKNO icon
1406
Alpha Teknova
TKNO
$266M
-300
Closed -$1K
TLRY icon
1407
Tilray
TLRY
$479M
-75,900
Closed -$685K
TLRY icon
1408
PUT
Tilray
TLRY
$479M
-75,500
Closed -$682K
TMHC icon
1409
Taylor Morrison
TMHC
$6.67B
-6,800
Closed -$400K
TNGX icon
1410
Tango Therapeutics
TNGX
$4.34B
-355
Closed -$3K
TRDA icon
1411
Entrada Therapeutics
TRDA
$227M
-150
Closed -$2K
TRVI icon
1412
Trevi Therapeutics
TRVI
$2.49B
-427
Closed -$5K
TSHA icon
1413
Taysha Gene Therapies
TSHA
$1.59B
-691
Closed -$4K
TVTX icon
1414
Travere Therapeutics
TVTX
$5.33B
-258
Closed -$10K
TWST icon
1415
Twist Bioscience
TWST
$5.62B
-210
Closed -$7K
TXG icon
1416
10x Genomics
TXG
$5.87B
-370
Closed -$6K
TXRH icon
1417
Texas Roadhouse
TXRH
$12.7B
-32,767
Closed -$5.44M
TYRA icon
1418
Tyra Biosciences
TYRA
$1.82B
-173
Closed -$5K
UDMY
1419
DELISTED
Udemy
UDMY
-4,100
Closed -$24K
UPST icon
1420
Upstart Holdings
UPST
$2.58B
-1,372
Closed -$60K
URGN icon
1421
UroGen Pharma
URGN
$2B
-160
Closed -$4K
USFD icon
1422
US Foods
USFD
$21.4B
-24,438
Closed -$1.84M
VCEL icon
1423
Vericel Corp
VCEL
$2.3B
-163
Closed -$6K
VCYT icon
1424
Veracyte
VCYT
$4.52B
-226
Closed -$10K
VERA icon
1425
Vera Therapeutics
VERA
$2.54B
-183
Closed -$9K

Similar funds

Daiwa Securities Group's Q1 2026 Portfolio in Review

As of Q1 2026, Daiwa Securities Group held 1,487 positions worth $34.8B, up 11% from $31.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group deployed $9.84B of net new capital in Q1 2026, opening 119 new positions and adding to 700 existing holdings. Its largest new stake was York Space Systems: 622,792 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was CrowdStrike, an estimated $612M trimmed.

  • Daiwa Securities Group's largest Q1 2026 buy was York Space Systems: 622,792 shares worth $13.8M.
  • Daiwa Securities Group added most to Microsoft in Q1 2026, an estimated $1.2B increase.
  • Daiwa Securities Group's biggest Q1 2026 reduction was CrowdStrike, cutting an estimated $612M.
  • Daiwa Securities Group fully exited iShares Bitcoin Trust in Q1 2026, selling an estimated $94.1M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $34.8B portfolio in Q1 2026.
  • Daiwa Securities Group opened 119 new positions and closed 311 in Q1 2026.
  • Daiwa Securities Group's portfolio value rose 11% quarter-over-quarter to $34.8B.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.